Article Information
History
- May 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maryam Kavousi1,*,
- Maxime M. Bos1,*,
- Hanna J. Barnes2,*,
- Christian L. Lino Cardenas2,*,
- Doris Wong3,4,*,
- the CHARGE Subclinical and Clinical Atherosclerosis Working Group,
- Christopher J. O’Donnell5,6,*,
- Lawrence F. Bielak7,*,
- Patricia A. Peyser7,*,
- Rajeev Malhotra2,*,
- Sander W. van der Laan8,*,** and
- Clint L. Miller4,9,*
- 1Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
- 2Cardiovascular Research Center, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 3Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, USA
- 4Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA
- 5Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 6Cardiology Section, Department of Medicine, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA
- 7Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
- 8Central Diagnostics Laboratory, Division Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 9Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA
- ↵** Corresponding author; email: s.w.vanderlaan-2{at}umcutrecht.nl
↵* authors contributed equally
Posted May 05, 2022.
Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification
